Opportunistic infections in Vancouver.
Marco
M
M
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017963:Azithromycin / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002177:Candidiasis / Q000188:drug therapy; D003586:Cytomegalovirus Infections / Q000150:complications / Q000517:prevention & control; D004317:Doxorubicin / Q000008:administration & dosage; D004337:Drug Carriers; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008081:Liposomes; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy; D012514:Sarcoma, Kaposi / Q000188:drug therapy; D014750:Vincristine / Q000008:administration & dosage
D000998:Antiviral Agents; D004337:Drug Carriers; D008081:Liposomes; D001761:Bleomycin; D014750:Vincristine; D004317:Doxorubicin; D017963:Azithromycin; D015774:Ganciclovir